Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs

OBJECTIVE: Despite evidence of effectiveness, pharmacotherapy—methadone, buprenorphine, or naltrexone—is prescribed to less than 35% of Veterans Health Administration (VHA) patients diagnosed with opioid use disorder (OUD).Among veterans whose OUD treatment is provided in VHA residential programs, f...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Stud Alcohol Drugs
Huvudupphovsmän: Finlay, Andrea K., Wong, Jessie J., Ellerbe, Laura S., Rubinsky, Anna, Gupta, Shalini, Bowe, Thomas R., Schmidt, Eric M., Timko, Christine, Burden, Jennifer L., Harris, Alex H. S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Rutgers University 2018
Ämnen:
Drug Overdose and Treatment
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6308173/
https://ncbi.nlm.nih.gov/pubmed/30573022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15288/jsad.2018.79.909
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk